Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Common Stock Equivalents (Details) - shares	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]
Total common stock equivalents excluded from dilutive loss per share	21,801	1,571,037
Holdback Shares [Member]
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]
Total common stock equivalents excluded from dilutive loss per share		4,000
Warrants - Public [Member]
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]
Total common stock equivalents excluded from dilutive loss per share		123,500
Warrants - Private [Member]
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]
Total common stock equivalents excluded from dilutive loss per share		108,100
Warrants - Series A [Member]
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]
Total common stock equivalents excluded from dilutive loss per share		205,333
Warrants - Series B [Member]
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]
Total common stock equivalents excluded from dilutive loss per share		513,333
Stock-based compensation - equity awards [Member]
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]
Total common stock equivalents excluded from dilutive loss per share	21,801	6,000
Forward Purchase Agreement - Additional Shares [Member]
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]
Total common stock equivalents excluded from dilutive loss per share		160,771
HBC Earnout Shares [Member]
Schedule of Potentially Dilutive Common Stock Equivalents [Line Items]
Total common stock equivalents excluded from dilutive loss per share		450,000